Among patients of child-bearing age, the crucial topic of whether cervical cancer impacts fertility frequently comes up ...

A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.

Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price target decreased by UBS Group from $5.00 to $2.20 in a research report released on Tuesday,Benzinga reports. UBS Group currently has ...

Height has been linked to an increased risk of certain cancers, including pancreatic, uterine, and breast cancer, due to ...

The genetic testing results also inform patients’ family members about their cancer risks so they can be proactive in screening and prevention. For now, GENETECA™ is only available to people with ...

T-DM1 sustained the improvement in invasive disease-free survival over trastuzumab in HER2-positive early breast cancer.

She first revealed her cancer diagnosis in March 2024, sharing that she'd be undergoing chemotherapy. Her next update came in June that year, when she said she still wasn't done with chemo and ...

Dwyane Wade reflected on having a cancerous tumor removed from his kidney as well as 40 percent of the organ itself after ...

Recent advances in immunotherapy have revolutionized the treatment of breast and gynecological cancers, and current ...

If you have metastatic breast cancer, you may need help from loved ones and your medical team along the way. Here’s how to ...

Paolo Tarantino, MD, PhD, discusses the approval of the oral therapy elacestrant for patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer with ESR1 mutations.

A mathematical modeling study conducted in Germany suggests that ovarian cancer incidence could be reduced and health care ...